Continuation Breakout Analysis — 2026-08-31

Overview

Today’s scan produced 18 continuation breakout signals, a healthy count that points to active rotation despite the broader Cautious regime. Breadth remains soft at 46.9% above the 40-day SMA and sentiment is Bearish/Bearish, so this is not a “buy everything” tape — it’s a stock-pickers environment where only the highest-conviction setups deserve size. Sector leadership is concentrated: Energy, Health Care and Communication Services show the strongest ATR%, and that shows up directly in our Top 10, where eight of ten candidates are Medical-sector names. That’s a theme trade, not broad-based strength, and it aligns well with the regime’s sector leadership data.

Quality Score: 3/5. Average RVOL across the list is modest (many names below 1.5x), institutional coverage is strong in a handful of large-cap names (WAT, MCK, PODD all carry 2,000+ funds), and the Medical cluster gives thematic conviction. Per the Cautious-regime rule, we’re capping enthusiasm and being selective — only the cleanest zone setups with real volume confirmation make the cut below.

Top 5 Picks

PODD ($148.66) — Medical / Medical-Products

Open full analysis on WaveFinder →

PODD is today’s standout on volume: RVOL 3.7x with a +2.4% move confirms real institutional participation, not a drift higher. Price has cleared a strong daily demand shelf (strength 8.1) and is pushing toward a well-defined 1h supply zone. This is the type of volume-backed continuation that justifies a slightly larger allocation even in a cautious tape.

Entry	Stop	Target
$148.66	$143.80	$152.57

Institutional Backing: 2,076 funds (INST), Bucket B2 — deep, established coverage.

MCK ($885.32) — Medical / Medical-Distribution

MCK sits directly at daily demand (strength 6.6) after a mild -0.9% pullback, with RVOL 1.4x showing buyers stepping in on the dip rather than distribution. With 3,500 institutional funds on record, this is the deepest institutional footprint in today’s list — a defensive Medical name that fits the Cautious-regime playbook of favoring quality over speculation.

Entry	Stop	Target
$885.32	$859.75	$920.35

Institutional Backing: 3,500 funds (INST) — largest institutional base in today’s scan.

WAT ($414.63) — Medical / Medical-Systems

Open full analysis on WaveFinder →

WAT is flat on the day but sitting right on top of a 1h demand zone (distance just 0.34%), with ATR%-M of 2.4 suggesting expanding volatility potential. Only 2.7% below its 52-week high, this is a well-established leader consolidating at support rather than breaking down — a classic low-risk continuation entry.

Entry	Stop	Target
$413.50	$410.00	$425.29

Institutional Backing: 2,530 funds (INST), Bucket B1.

ASND ($263.04) — Medical / Profitable Biotech

Open full analysis on WaveFinder →

ASND is today’s momentum leader: +6.1% on RVOL 2.1x, now pressing directly into a tight 1h supply zone just 0.47% away. A clean break above $265.15 on continued volume would confirm a breakout through resistance. Aggressive traders can use the supply zone as a trigger; this is a higher-beta, higher-reward play relative to the rest of the list.

Entry	Stop	Target
$265.15	$258.50	$278.00

Institutional Backing: 593 funds, Buckets B1/B2.

TARS ($74.24) — Medical / Revenue Biotech

TARS shows the highest ATR%-M in today’s list (4.0), signaling expanding volatility with room to run. Price sits between demand (70.73–71.76) and a monthly supply zone (79.67–85.25), giving a favorable risk/reward band with +3.5% momentum already building on the day.

Entry	Stop	Target
$74.24	$70.73	$79.67

Institutional Backing: 394 funds, Buckets B0/B1.

Honorable Mentions

ONC ($359.58) — Pulling back -1.9% between zones; wait for confirmation before entry despite strong ATR%-M of 3.8.
SPRY ($6.00) — Small-cap biotech at supply with 6.8% ADR; high risk, speculative only.
SKHY ($164.58) — At supply with zero institutional coverage; technical setup lacks sponsorship confirmation.
OMDA ($24.55) — At demand but supply overhead just 0.08% away leaves very little room to run.
MOS ($24.12) — Agriculture name at supply with tight 0.26% resistance; needs a clean breakout to justify entry.

Strategy Summary

Today’s setups are dominated by the Medical sector, consistent with its top-3 ATR% ranking in the current regime. Given the Cautious backdrop and below-average breadth, we favor names with confirmed volume (PODD, ASND) and heavy institutional sponsorship (MCK, WAT) over lower-conviction, thinly-covered breakouts. Risk/reward is favorable across the Top 5, with defined demand-zone stops and supply-zone targets offering roughly 2:1 to 3:1 reward-to-risk. Position sizing should stay conservative until breadth and sentiment improve.